Mavorixafor Disease Interactions
There are 3 disease interactions with mavorixafor.
Mavorixafor (applies to mavorixafor) liver disease
Moderate Potential Hazard, Moderate plausibility.
Mavorixafor is not recommended in patients with moderate to severe liver dysfunction.
Mavorixafor (applies to mavorixafor) QTc prolongation
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Long QT Syndrome, Hypokalemia
Mavorixafor causes concentration-dependent QTc interval prolongation. Correct any modifiable risk factors for QTc prolongation (e.g., hypokalemia), assess QTc at baseline and monitor during treatment as clinically indicated.
Mavorixafor (applies to mavorixafor) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Mavorixafor is not recommended in patients with severe renal impairment and end stage renal disease.
Switch to professional interaction data
Mavorixafor drug interactions
There are 624 drug interactions with mavorixafor.
Mavorixafor alcohol/food interactions
There is 1 alcohol/food interaction with mavorixafor.
Report options
More about mavorixafor
- mavorixafor consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: other immunostimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Xolremdi
Xolremdi is used to treat WHIM syndrome in adults and children 12 years of age and older to ...
Mozobil
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected ...
Plerixafor
Plerixafor systemic is used for hematopoietic stem cell mobilization, multiple myeloma ...
Glatiramer
Glatiramer acetate (brand name Copaxone, Glatopa, and generics) is used to treat relapsing forms of ...
Elapegademase
Elapegademase systemic is used for adenosine deaminase deficiency
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
